Get the Stockscreener App
20.50
0.15%
0.03
Pre-market:
22.00
1.50
+7.32%
Precipio Inc stock is traded at $20.50, with a volume of 6,023.
It is up +0.15% in the last 24 hours and up +15.23% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$20.47
Open:
$20.66
24h Volume:
6,023
Relative Volume:
0.40
Market Cap:
$33.20M
Revenue:
$21.24M
Net Income/Loss:
$-1.80M
P/E Ratio:
-16.95
EPS:
-1.2094
Net Cash Flow:
$565.00K
1W Performance:
-0.24%
1M Performance:
+15.23%
6M Performance:
+236.98%
1Y Performance:
+219.81%
1-Day Range:
$19.98
$20.66
1-Week Range:
$19.98
$21.67
52-Week Range:
$3.90
$22.38
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
20.50 | 33.15M | 21.24M | -1.80M | 565.00K | -1.2094 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Precipio Inc Stock (PRPO) Latest News
Can Precipio Inc. stock withstand economic slowdown2025 Analyst Calls & Momentum Based Trading Signals - newser.com
What sentiment indicators say about Precipio Inc. stockJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Why Precipio Inc. stock is favored by pension fundsIndex Update & AI Enhanced Trading Alerts - newser.com
Precipio Inc. stock volume spike explainedJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Published on: 2025-11-01 08:42:18 - newser.com
Historical volatility pattern of Precipio Inc. visualizedGap Up & Community Consensus Stock Picks - newser.com
Precipio Inc. stock chart pattern explainedPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com
How rising interest rates impact Precipio Inc. stock2025 Key Lessons & Free Verified High Yield Trade Plans - newser.com
Precipio Inc. stock daily chart insightsVolume Spike & Weekly Breakout Watchlists - newser.com
Is this a good reentry point in Precipio Inc.CEO Change & Long-Term Capital Growth Strategies - newser.com
Is Precipio Inc. stock undervalued vs historical averagesJuly 2025 Institutional & Capital Efficient Trading Techniques - fcp.pa.gov.br
Chart Watch: Is Precipio Inc. stock undervalued vs historical averages2025 Winners & Losers & Low Drawdown Investment Strategies - Fundação Cultural do Pará
Can Precipio Inc. stock sustain market leadershipJuly 2025 Review & Low Drawdown Investment Strategies - Fundação Cultural do Pará
Automated trading signals detected on Precipio Inc.Portfolio Performance Report & Stock Market Timing Techniques - newser.com
Risk vs reward if holding onto Precipio Inc.Portfolio Profit Report & High Yield Equity Trading Tips - newser.com
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):